What is HealthEquity's accrued manufacturing costs?

HealthEquity (HQY) reported accrued manufacturing costs of $26.66M in Q1 2026.

How has HealthEquity's accrued manufacturing costs changed year-over-year?

HealthEquity's accrued manufacturing costs increased by 9.1% year-over-year, from $24.43M to $26.66M.

What is the long-term trend for HealthEquity's accrued manufacturing costs?

Over 5 years (2021 to 2026), HealthEquity's accrued manufacturing costs has grown at a 3.6% compound annual growth rate (CAGR), from $50.67M to $60.39M.

HealthEquity HQY Accrued Manufacturing Costs

Other financials

Income statement

See full

Revenue$354.6M+7.2%

Gross profit$256.3M+14.3%

Operating income$103.0M+23.9%

Net income$69.4M+28.8%

EPS (diluted)$0.82+34.4%

Balance sheet

See full

Cash & equivalents$265.4M-7.8%

Total debt$984.7M-11.0%

Total equity$2.0B-3.6%

Total assets$3.3B-3.2%

Cash flow

See full

Operating cash flow$97.5M+50.6%

CapEx$362.0K+321%

Free cash flow$97.2M+50.3%

Valuation

See full

Market cap$7.12B-6.7%

Enterprise value$7.84B-7.2%

P/E30.9×-31.8×

P/S5.3×-0.8×

Profitability

See full

Gross margin70.7%+5.2pp

Operating margin25.6%+9.2pp

Net margin17.3%+7.5pp

FCF margin36.5%+9.3pp

Returns & leverage

See full

Return on equity11.1%+5.3pp

Debt / equity0.5×0.0×

Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's accrued manufacturing costs.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HealthEquity's accrued manufacturing costs?: HealthEquity (HQY) reported accrued manufacturing costs of $26.66M in Q1 2026.
How has HealthEquity's accrued manufacturing costs changed year-over-year?: HealthEquity's accrued manufacturing costs increased by 9.1% year-over-year, from $24.43M to $26.66M.
What is the long-term trend for HealthEquity's accrued manufacturing costs?: Over 5 years (2021 to 2026), HealthEquity's accrued manufacturing costs has grown at a 3.6% compound annual growth rate (CAGR), from $50.67M to $60.39M.